Drug Type Recombinant vector vaccine, Prophylactic vaccine |
Synonyms- |
Action stimulants, inhibitors |
Mechanism CD8 stimulants(Cluster of differentiation 8 stimulants), KRAS G12C inhibitors(GTPase KRas G12C inhibitors), KRAS G12D inhibitors(GTPase KRas G12D inhibitors) + [3] |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | United States | 24 May 2024 |